These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12396818)

  • 1. Biochemical markers: con.
    Mitsumoto H
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S83. PubMed ID: 12396818
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical markers: pro.
    Rothstein J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S81. PubMed ID: 12396817
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical markers: summary.
    Strong MJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S85-90. PubMed ID: 12396819
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival endpoint: con.
    Rosenfeld J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S37-9. PubMed ID: 12396803
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative compound muscle action potential: con.
    Dengler R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S105-7. PubMed ID: 12396825
    [No Abstract]   [Full Text] [Related]  

  • 6. Motor unit number estimation: con.
    Bromberg MB
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S95. PubMed ID: 12396822
    [No Abstract]   [Full Text] [Related]  

  • 7. Endpoint considerations for clinical trials.
    Walton MK
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S3-6. PubMed ID: 12396791
    [No Abstract]   [Full Text] [Related]  

  • 8. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 9. Compound muscle action potential: pro.
    De Carvalho M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S103-4. PubMed ID: 12396824
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of strength: con.
    Sorenson E
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S49-50. PubMed ID: 12396806
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative compound muscle action potential: summary.
    Petajan JH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S109-10. PubMed ID: 12396826
    [No Abstract]   [Full Text] [Related]  

  • 12. Motor Unit Number Estimation (MUNE): pro.
    Olney RK
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S91-2. PubMed ID: 12396820
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy development for ALS: lessons learned and path forward.
    Lanka V; Cudkowicz M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):131-40. PubMed ID: 18574756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver assessment: con.
    Ross MA
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S29. PubMed ID: 12396800
    [No Abstract]   [Full Text] [Related]  

  • 15. Motor unit number estimation: pro.
    Gooch CL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S93-4. PubMed ID: 12396821
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS.
    Henkel JS; Beers DR; Wen S; Bowser R; Appel SH
    Neurology; 2009 May; 72(18):1614-6. PubMed ID: 19414730
    [No Abstract]   [Full Text] [Related]  

  • 17. Vital capacity as an efficacy measure: con.
    Jackson CE
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S59-60. PubMed ID: 12396809
    [No Abstract]   [Full Text] [Related]  

  • 18. Motor unit number estimation: summary.
    Shefner JM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S97-102. PubMed ID: 12396823
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging: MRS, MRI, PET/SPECT: con.
    Kalra S; Arnold DL
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S73-4. PubMed ID: 12396815
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergent Measure for Clinical Trials: TMS - con.
    Weber M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S113-6. PubMed ID: 12396828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.